BiotechTube
Source BioScience

Source BioScience

Nottingham, United Kingdom· Est.
sourcebioscience.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Source BioScience, founded in 1996 and headquartered in Nottingham, UK, is a private, revenue-generating laboratory services company. It provides essential genomic, proteomic, and histopathology services to support R&D and clinical diagnostics for biopharma and healthcare clients. The company's model is built on technical expertise, competitive pricing, and strong customer service, as evidenced by client testimonials. Its recent expansion into next-generation proteomics (Alamar Proteomics) indicates a strategic move to broaden its service portfolio in the high-growth life sciences tools and diagnostics market.

Antibodies

Technology Platform

Suite of laboratory service technologies including Sanger sequencing, Next-Generation Sequencing (NGS), Nanopore sequencing, and next-generation proteomics (Alamar Proteomics) for protein analysis, combined with histopathology and digital pathology services.

Opportunities

Growth in outsourced life sciences R&D and clinical testing, particularly in genomics and proteomics for drug development and personalized medicine.
Expansion of its recently launched Alamar Proteomics service represents a direct opportunity in the high-growth proteomics market.
Its UK base offers a logistical advantage for local biopharma and academic clients.

Risk Factors

Faces intense competition from large global CROs and niche service providers.
Rapid technological change requires constant capital investment to avoid obsolescence.
Revenue is tied to client R&D budgets, which are sensitive to economic cycles and funding environments.

Competitive Landscape

Operates in the crowded contract research and laboratory services market. Competitors range from large, full-service global CROs (e.g., LabCorp, IQVIA, Charles River) to specialized genomics (e.g., Eurofins Genomics, GENEWIZ) and pathology service providers. Differentiation is achieved through integrated service offerings, customer service, rapid turnaround, and competitive pricing within the UK/European region.

More companies in United Kingdom →